Sarepta Therapeutics (SRPT) Stock
Sarepta Therapeutics (SRPT) closed at $14.77 on Nov 17, 2026; its Tenet Score is 48 of 100 against 340 Healthcare peers.
20 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $14.77
- Nov 17, 2026
- Market cap
- $1.6B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 14.68 – 24.68
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 48/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Sarepta Therapeutics Inc scores 48/100. Mixed. Strongest on value, quality is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 5…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Agios Pharmaceuticals IncAGIO | 64 | $1.8B |
| Stoke Therapeutics IncSTOK | 50 | $1.7B |
| Certara IncCERT | 48 | $1.7B |
| Vir Biotechnology IncVIR | 54 | $1.6B |
| ANI Pharmaceuticals IncANIP | 69 | $1.6B |
| Nurix Therapeutics IncNRIX | 84 | $1.6B |
| uniQure N.V.QURE | 37 | $1.5B |
| SELLAS Life Sciences Group IncSLS | 42 | $1.5B |
| Immunocore Holdings plcIMCR | 53 | $1.5B |
| Pacira BioSciences IncPCRX | 56 | $1.5B |
Common questions
What sector and industry is Sarepta Therapeutics in?
Sarepta Therapeutics is in the Healthcare sector and the Drugs industry.
What is Sarepta Therapeutics' Tenet Score?
Sarepta Therapeutics' Tenet Score is 48 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




